KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Income from Continuing Operations (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Income from Continuing Operations for 16 consecutive years, with 1791000000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Income from Continuing Operations rose 11.45% year-over-year to 1791000000.0, compared with a TTM value of 6379000000.0 through Dec 2024, up 6.07%, and an annual FY2025 reading of 6761000000.0, up 5.97% over the prior year.
  • Income from Continuing Operations was 1791000000.0 for Q4 2024 at Thermo Fisher Scientific, up from 1643000000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 2503000000.0 in Q4 2020 and bottomed at 788000000.0 in Q1 2020.
  • Average Income from Continuing Operations over 5 years is 1681650000.0, with a median of 1651000000.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations skyrocketed 196.57% in 2021, then tumbled 41.18% in 2023.
  • Year by year, Income from Continuing Operations stood at 2503000000.0 in 2020, then plummeted by 33.72% to 1659000000.0 in 2021, then fell by 3.32% to 1604000000.0 in 2022, then rose by 0.19% to 1607000000.0 in 2023, then rose by 11.45% to 1791000000.0 in 2024.
  • Business Quant data shows Income from Continuing Operations for TMO at 1791000000.0 in Q4 2024, 1643000000.0 in Q3 2024, and 1637000000.0 in Q2 2024.